• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单中心型和多中心型Castleman病的基因异常综述

A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

作者信息

Butzmann Alexandra, Kumar Jyoti, Sridhar Kaushik, Gollapudi Sumanth, Ohgami Robert S

机构信息

Agilent Technologies, Santa Clara, CA 95051, USA.

Department of Pathology, Stanford University, Stanford, CA 94305, USA.

出版信息

Biology (Basel). 2021 Mar 24;10(4):251. doi: 10.3390/biology10040251.

DOI:10.3390/biology10040251
PMID:33804823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8063830/
Abstract

Castleman disease (CD) is a rare lymphoproliferative disorder known to represent at least four distinct clinicopathologic subtypes. Large advancements in our clinical and histopathologic description of these diverse diseases have been made, resulting in subtyping based on number of enlarged lymph nodes (unicentric versus multicentric), according to viral infection by human herpes virus 8 (HHV-8) and human immunodeficiency virus (HIV), and with relation to clonal plasma cells (POEMS). In recent years, significant molecular and genetic abnormalities associated with CD have been described. However, we continue to lack a foundational understanding of the biological mechanisms driving this disease process. Here, we review all cases of CD with molecular abnormalities described in the literature to date, and correlate cytogenetic, molecular, and genetic abnormalities with disease subtypes and phenotypes. Our review notes complex karyotypes in subsets of cases, specific mutations in N666S in 10% of unicentric CD (UCD) and L261F in 23% of idiopathic multicentric CD (iMCD) cases. Genes affecting chromatin organization and abnormalities in methylation are seen more commonly in iMCD while abnormalities within the mitogen-activated protein kinase (MAPK) and interleukin signaling pathways are more frequent in UCD. Interestingly, there is a paucity of genetic studies evaluating HHV-8 positive multicentric CD (HHV-8+ MCD) and POEMS-associated CD. Our comprehensive review of genetic and molecular abnormalities in CD identifies subtype-specific and novel pathways which may allow for more targeted treatment options and unique biologic therapies.

摘要

卡斯特曼病(CD)是一种罕见的淋巴增生性疾病,已知至少有四种不同的临床病理亚型。我们在对这些不同疾病的临床和组织病理学描述方面取得了重大进展,从而根据肿大淋巴结的数量(单中心与多中心)、是否感染人类疱疹病毒8型(HHV - 8)和人类免疫缺陷病毒(HIV)以及与克隆性浆细胞的关系(POEMS)进行了亚型分类。近年来,已经描述了与CD相关的显著分子和基因异常。然而,我们仍然缺乏对驱动这一疾病进程的生物学机制的基本理解。在此,我们回顾了迄今为止文献中描述的所有伴有分子异常的CD病例,并将细胞遗传学、分子和基因异常与疾病亚型及表型相关联。我们的综述指出,部分病例存在复杂核型,10%的单中心型CD(UCD)有N666S特异性突变,23%的特发性多中心型CD(iMCD)病例有L261F突变。影响染色质组织的基因和甲基化异常在iMCD中更常见,而丝裂原活化蛋白激酶(MAPK)和白细胞介素信号通路的异常在UCD中更频繁。有趣的是,评估HHV - 8阳性多中心型CD(HHV - 8 + MCD)和POEMS相关CD的基因研究很少。我们对CD的基因和分子异常进行的全面综述确定了亚型特异性和新的途径,这可能会带来更有针对性的治疗选择和独特的生物疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/ada0959d2ddd/biology-10-00251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/72eee06d81f3/biology-10-00251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/ab89afea3ebb/biology-10-00251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/71d69c53f7e9/biology-10-00251-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/ada0959d2ddd/biology-10-00251-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/72eee06d81f3/biology-10-00251-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/ab89afea3ebb/biology-10-00251-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/71d69c53f7e9/biology-10-00251-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b91d/8063830/ada0959d2ddd/biology-10-00251-g004.jpg

相似文献

1
A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.单中心型和多中心型Castleman病的基因异常综述
Biology (Basel). 2021 Mar 24;10(4):251. doi: 10.3390/biology10040251.
2
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.病毒组捕获测序不能在局灶性和特发性多中心 Castleman 病中识别出活跃的病毒感染。
PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019.
3
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.特发性多中心和单中心 Castleman 病及滤泡树突状细胞肉瘤的下一代测序。
Blood Adv. 2018 Mar 13;2(5):481-491. doi: 10.1182/bloodadvances.2017009654.
4
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms.Castleman 病中的 T 细胞亚群:包括单中心、多中心和 HHV8 相关临床形式的 28 例分析。
Int J Mol Sci. 2023 Apr 25;24(9):7813. doi: 10.3390/ijms24097813.
5
Castleman Disease: A Rare Lymphoproliferative Disorder With Diverse Clinical Presentation, Diagnosis, and Treatment Approach.卡斯特曼病:一种临床表现、诊断及治疗方法多样的罕见淋巴增殖性疾病。
Cureus. 2024 Sep 11;16(9):e69149. doi: 10.7759/cureus.69149. eCollection 2024 Sep.
6
From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.从 Castleman 病的组织病理学特征到特发性多中心 Castleman 病:一种排除潜在 iMCD 组织病理学模拟物的多参数方法。
J Clin Pathol. 2024 Apr 18;77(5):318-323. doi: 10.1136/jcp-2022-208696.
7
TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.TAFRO综合征:特发性多中心Castleman病的新亚型。
Bosn J Basic Med Sci. 2017 May 20;17(2):81-84. doi: 10.17305/bjbms.2017.1930.
8
Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.HIV和HHV-8阴性的Castleman病的临床和病理特征
Blood. 2017 Mar 23;129(12):1658-1668. doi: 10.1182/blood-2016-11-748855. Epub 2017 Jan 18.
9
Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report.无塔夫罗综合征的特发性多中心Castleman病中的特殊高血管表现:一例报告
Ann Hematol. 2024 Dec;103(12):5929-5934. doi: 10.1007/s00277-024-06040-z. Epub 2024 Oct 14.
10
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.一项在中国开展的采用Castleman病协作网(CDCN)标准的Castleman病全国多中心回顾性研究。
Lancet Reg Health West Pac. 2023 Mar 24;34:100720. doi: 10.1016/j.lanwpc.2023.100720. eCollection 2023 May.

引用本文的文献

1
The morphological spectrum of Castleman disease and related disorders: a report from the Lymphoma Workshop of the 22nd Meeting of the European Association of Hematopathology.Castleman病及相关疾病的形态学谱:欧洲血液病理学协会第22次会议淋巴瘤研讨会报告
Virchows Arch. 2025 Jul 12. doi: 10.1007/s00428-025-04171-w.
2
Castleman Disease-Still More Questions than Answers: A Case Report and Review of the Literature.卡斯特曼病——问题仍多于答案:一例病例报告及文献综述
J Clin Med. 2025 Apr 18;14(8):2799. doi: 10.3390/jcm14082799.
3
Castleman Disease: A Rare Lymphoproliferative Disorder With Diverse Clinical Presentation, Diagnosis, and Treatment Approach.

本文引用的文献

1
Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.经典型霍奇金淋巴瘤和血管滤泡性淋巴结增生症:一种实体似乎正在出现。
Virchows Arch. 2020 Sep;477(3):437-444. doi: 10.1007/s00428-020-02788-7. Epub 2020 Mar 9.
2
Genetic basis for iMCD-TAFRO.iMCD-TAFRO 的遗传学基础。
Oncogene. 2020 Apr;39(15):3218-3225. doi: 10.1038/s41388-020-1204-9. Epub 2020 Feb 12.
3
Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review.外周T细胞淋巴瘤合并Castleman病:一例报告及文献复习
卡斯特曼病:一种临床表现、诊断及治疗方法多样的罕见淋巴增殖性疾病。
Cureus. 2024 Sep 11;16(9):e69149. doi: 10.7759/cureus.69149. eCollection 2024 Sep.
4
A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy.关于连续性肾脏替代治疗重症多中心 Castleman 病的治疗策略假说。
J Cell Mol Med. 2024 Sep;28(17):e70026. doi: 10.1111/jcmm.70026.
5
Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report.以十年贫血为腹腔Castleman病初始表现:一例报告
Open Life Sci. 2024 Jun 27;19(1):20220898. doi: 10.1515/biol-2022-0898. eCollection 2024.
6
TAFRO Syndrome and COVID-19.TAFRO综合征与新型冠状病毒肺炎
Biomedicines. 2024 Jun 11;12(6):1287. doi: 10.3390/biomedicines12061287.
7
Radiological Imaging Findings of Adrenal Abnormalities in TAFRO Syndrome: A Systematic Review.TAFRO综合征肾上腺异常的放射影像学表现:一项系统评价
Biomedicines. 2024 Apr 10;12(4):837. doi: 10.3390/biomedicines12040837.
8
Solitary hyoid plasmacytoma with unicentric Castleman disease: A case report and review of literature.孤立性舌骨浆细胞瘤合并单中心Castleman病:一例报告及文献复习
World J Clin Cases. 2022 Dec 26;10(36):13364-13372. doi: 10.12998/wjcc.v10.i36.13364.
9
Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.特发性多中心 Castleman 病及相关自身免疫和自身炎症性疾病:诊断的实用指南。
Rheumatology (Oxford). 2023 Apr 3;62(4):1426-1435. doi: 10.1093/rheumatology/keac481.
10
International definition of iMCD-TAFRO: future perspectives.iMCD-TAFRO 的国际定义:未来展望。
J Clin Exp Hematop. 2022 Jun 28;62(2):73-78. doi: 10.3960/jslrt.21037. Epub 2022 Apr 27.
Medicine (Baltimore). 2020 Jan;99(2):e18650. doi: 10.1097/MD.0000000000018650.
4
Whole-exome sequencing identifies novel somatic alterations associated with outcomes in idiopathic multicentric Castleman disease.全外显子组测序鉴定出与特发性多中心Castleman病预后相关的新型体细胞改变。
Br J Haematol. 2020 Mar;188(5):e64-e67. doi: 10.1111/bjh.16330. Epub 2019 Dec 21.
5
Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.血小板衍生生长因子受体B(PDGFRB)突变与儿童肌纤维瘤及肌纤维瘤病的关联
JAMA Dermatol. 2019 Aug 1;155(8):946-950. doi: 10.1001/jamadermatol.2019.0114.
6
Recurrent PDGFRB mutations in unicentric Castleman disease.单中心Castleman病中的复发性血小板衍生生长因子受体B(PDGFRB)突变
Leukemia. 2019 Apr;33(4):1035-1038. doi: 10.1038/s41375-018-0323-6. Epub 2019 Jan 3.
7
Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的新见解和治疗方法。
Blood. 2018 Nov 29;132(22):2323-2330. doi: 10.1182/blood-2018-05-848671.
8
Pleural Mucosa-associated Lymphoid Tissue Lymphoma with Trisomy 18.伴有18号染色体三体的胸膜黏膜相关淋巴组织淋巴瘤
Intern Med. 2019 Mar 15;58(6):891-892. doi: 10.2169/internalmedicine.1780-18. Epub 2018 Nov 19.
9
A novel mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease.一个家族中存在单一中心型和特发性多中心型血管滤泡性淋巴结增生症的具有可变外显率的新型突变。
Blood Adv. 2018 Nov 13;2(21):2959-2963. doi: 10.1182/bloodadvances.2018023911.
10
COSMIC: the Catalogue Of Somatic Mutations In Cancer.COSMIC:癌症体细胞突变目录。
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947. doi: 10.1093/nar/gky1015.